Trial Profile
Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Malignant thymoma
- Focus Therapeutic Use
- 19 Jan 2012 Actual patient number (11) added as reported by ClinicalTrials.gov.
- 19 Jan 2012 Actual end date (1 Mar 2011 ) added as reported by ClinicalTrials.gov.
- 19 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.